Literature DB >> 11900779

A simple procedure for assessing ataxia in rats: effects of phencyclidine.

Susan M Melnick1, Jennifer S Rodriguez, Rick E Bernardi, Aaron Ettenberg.   

Abstract

The present study describes an objective, cost- and time-efficient procedure for characterizing the ataxic effects of psychoactive drugs. Male Sprague-Dawley rats were administered an intraperitoneal injection of either saline or one of three doses (1, 5 or 10 mg/kg) of phencyclidine (PCP) 15 min prior to being placed into an empty standard operant conditioning chamber (all manipulanda were removed). The floor of the test apparatus consisted of parallel rows of metal rods spaced approximately 1.5 cm apart. During a 5-min test, a single observer counted the frequency with which each animal's paws (front or back) slipped between the rows of bars that constituted the cage floor. The data demonstrated that while saline animals exhibited no instability in their ambulation, PCP-treated animals demonstrated a highly reliable dose-dependent increase in the number of "paw slips" in a single trial. Since animals are known to develop tolerance to the ataxic response to PCP, the validity of the test as a measure of drug-induced ataxia was examined in a separate group of animals treated with the middle (5 mg/kg) dose every other day over the course of a 9-day period (i.e., resulting in five injection trials). In this experiment, each subsequent test produced a reliable reduction in the magnitude of the ataxic response, and by the fifth drug challenge, the PCP animals were performing at near-control levels. These results suggest that the "paw slip test" can serve as a simple, reliable, objective and valid measure of drug-induced ataxia. The relevance of the ataxia data for interpreting the locomotor response of animals treated with PCP is also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900779     DOI: 10.1016/s0091-3057(01)00727-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.

Authors:  Nurith Amitai; Athina Markou
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

Review 2.  Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia.

Authors:  Nurith Amitai; Athina Markou
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

3.  Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats.

Authors:  Nurith Amitai; Ronald Kuczenski; M Margarita Behrens; Athina Markou
Journal:  Neuropharmacology       Date:  2011-01-14       Impact factor: 5.250

4.  Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.

Authors:  Stephen J Kohut; Nancy A Ator
Journal:  Pharmacol Biochem Behav       Date:  2008-02-26       Impact factor: 3.533

5.  Global quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex.

Authors:  D B McClatchy; J N Savas; S Martínez-Bartolomé; S K Park; P Maher; S B Powell; J R Yates
Journal:  Mol Psychiatry       Date:  2015-04-14       Impact factor: 15.992

6.  Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.

Authors:  Nurith Amitai; Svetlana Semenova; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2007-05-12       Impact factor: 4.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.